Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques

Vaccine

Volumn 28, Issue 8, 2010, Pages 1942-1951

  Kraynyak, Kimberly A ^a   Kutzler, Michele A ^b   Cisper, Neil J ^a   Khan, Amir S ^c   Draghia Akli, Ruxandra ^c   Sardesal, Niranjan Y ^c   Lewis, Mark G ^d   Yan, Jian ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Inovio Biomedical   (United States)

^d BIOQUAL INC   (United States)

Author keywords

Adjuvant; CCL27; DNA vaccine; HIV 1; Mucosal

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CUTANEOUS T CELL ATTRACTING CHEMOKINE; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DNA IMMUNIZATION; ELECTROPORATION; FECES ANALYSIS; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; INFLAMMATION; LUNG LAVAGE; MACACA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINE CCL27; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGLOBULIN A; INTERFERON-GAMMA; MACACA; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; PLASMIDS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TRANSFECTION; VACCINES, DNA;

EID: 76949103994     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.095     Document Type: Article

References (45)

1. Schoenly K.A., and Weiner D.B. Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". Journal of Virology 82 April (7) (2008) 3166-3180
2. Hokey D.A., and Weiner D.B. DNA vaccines for HIV: challenges and opportunities. Springer Seminars in Immunopathology 28 November (3) (2006) 267-279
3. Gao F., Li Y., Decker J.M., Peyerl F.W., Bibollet-Ruche F., Rodenburg C.M., et al. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Research and Human Retroviruses 19 September (9) (2003) 817-823
4. Leifert J.A., Rodriguez-Carreno M.P., Rodriguez F., and Whitton J.L. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunological Reviews 199 June (2004) 40-53
5. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 September (1) (2006) 86-97 [San Diego, CA]
6. Lee S., Gierynska M., Eo S.K., Kuklin N., and Rouse B.T. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes and Infection/Institut Pasteur 5 June (7) (2003) 571-578
7. Kaneko H., Bednarek I., Wierzbicki A., Kiszka I., Dmochowski M., Wasik T.J., et al. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology 267 February (1) (2000) 8-16
8. Kusakabe K., Xin K.Q., Katoh H., Sumino K., Hagiwara E., Kawamoto S., et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. Journal of Immunology 164 March (6) (2000) 3102-3111
9. Biragyn A., Belyakov I.M., Chow Y.H., Dimitrov D.S., Berzofsky J.A., and Kwak L.W. DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 100 August (4) (2002) 1153-1159
10. Bagarazzi M.L., Boyer J.D., Javadian M.A., Chattergoon M.A., Shah A.R., Cohen A.D., et al. Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees. The Journal of Infectious Diseases 180 October (4) (1999) 1351-1355
11. Wang B., Dang K., Agadjanyan M.G., Srikantan V., Li F., Ugen K.E., et al. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine 15 June (8) (1997) 821-825
12. Sin J., Kim J.J., Pachuk C., Satishchandran C., and Weiner D.B. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. Journal of Virology 74 December (23) (2000) 11173-11180
13. Kim J.J., Yang J.S., Dentchev T., Dang K., and Weiner D.B. Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 20 May (5) (2000) 487-498
14. Boyer J.D., Kim J., Ugen K., Cohen A.D., Ahn L., Schumann K., et al. HIV-1 DNA vaccines and chemokines. Vaccine 17 October (Suppl. 2) (1999) S53-64
15. Sumida S.M., McKay P.F., Truitt D.M., Kishko M.G., Arthur J.C., Seaman M.S., et al. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. The Journal of Clinical Investigation 114 November (9) (2004) 1334-1342
16. Ishikawa-Mochizuki I., Kitaura M., Baba M., Nakayama T., Izawa D., Imai T., et al. Molecular cloning of a novel CC chemokine, interleukin-11 receptor alpha-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus. FEBS Letters 460 November (3) (1999) 544-548
17. Morales J., Homey B., Vicari A.P., Hudak S., Oldham E., Hedrick J., et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proceedings of the National Academy of Sciences of the United States of America 96 December (25) (1999) 14470-14475
18. Baird J.W., Nibbs R.J., Komai-Koma M., Connolly J.A., Ottersbach K., Clark-Lewis I., et al. ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. The Journal of Biological Chemistry 274 November (47) (1999) 33496-33503
19. Hromas R., Broxmeyer H.E., Kim C., Christopherson II K., and Hou Y.H. Isolation of ALP, a novel divergent murine CC chemokine with a unique carboxy terminal extension. Biochemical and Biophysical Research Communications 258 May (3) (1999) 737-740
20. Homey B., Wang W., Soto H., Buchanan M.E., Wiesenborn A., Catron D., et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). Journal of Immunology 164 April (7) (2000) 3465-3470
21. Kunkel E.J., Kim C.H., Lazarus N.H., Vierra M.A., Soler D., Bowman E.P., et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. The Journal of Clinical Investigation 111 April (7) (2003) 1001-1010
22. Nakazato J., Kishida M., Kuroiwa R., Fujiwara J., Shimoda M., and Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatric Allergy and Immunology 19 November (7) (2008) 605-613
23. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. The Journal of Allergy and Clinical Immunology 111 March (3) (2003) 592-597
24. Homey B., Alenius H., Muller A., Soto H., Bowman E.P., Yuan W., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nature Medicine 8 February (2) (2002) 157-165
25. Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, Maguire H, Muthumani K, Ugen K, Weiner DB. Plasmid DNA encoding the CCR10 ligands CCL27 and CCL28 adjuvant vaccine elicited immuity in vivo. Gene Therapy 2009 Oct 22. [Epub ahead of print].
26. Qiu L., Huang D., Chen C.Y., Wang R., Shen L., Shen Y., et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. The Journal of Infectious Diseases 198 November (10) (2008) 1514-1519
27. Kim J.J., Nottingham L.K., Sin J.I., Tsai A., Morrison L., Oh J., et al. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. The Journal of Clinical Investigation 102 September (6) (1998) 1112-1124
28. Yan J., Hokey D.A., Morrow M.P., Corbitt N., Harris K., Harris D., et al. Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques. Vaccine February (2009) 4
29. Kutzler M.A., Robinson T.M., Chattergoon M.A., Choo D.K., Choo A.Y., Choe P.Y., et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. Journal of Immunology 175 July (1) (2005) 112-123
30. Hirao L.A., Wu L., Khan A.S., Hokey D.A., Yan J., Dai A., et al. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26 June (25) (2008) 3112-3120
31. Laddy D.J., Yan J., Kutzler M., Kobasa D., Kobinger G.P., Khan A.S., et al. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE 3 6 (2008) e2517
32. Boyer J.D., Robinson T.M., Kutzler M.A., Parkinson R., Calarota S.A., Sidhu M.K., et al. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. Journal of Medical Primatology 34 October (5-6) (2005) 262-270
33. Robinson H.L. HIV/AIDS vaccines: 2007. Clinical Pharmacology and Therapeutics 82 December (6) (2007) 686-693
34. Koff W.C., Johnson P.R., Watkins D.I., Burton D.R., Lifson J.D., Hasenkrug K.J., et al. HIV vaccine design: insights from live attenuated SIV vaccines. Nature Immunology 7 January (1) (2006) 19-23
35. Saurer L., McCullough K.C., and Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. Journal of Immunology 179 September (6) (2007) 3504-3514
36. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nature Immunology 8 March (3) (2007) 285-293
37. Sigmundsdottir H., and Butcher E.C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nature Immunology 9 September (9) (2008) 981-987
38. Belyakov I.M., Hammond S.A., Ahlers J.D., Glenn G.M., and Berzofsky J.A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. The Journal of Clinical Investigation 113 April (7) (2004) 998-1007
39. Berry L.J., Hickey D.K., Skelding K.A., Bao S., Rendina A.M., Hansbro P.M., et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infection and Immunity 72 February (2) (2004) 1019-1028
40. Glenn G.M., Scharton-Kersten T., Vassell R., Mallett C.P., Hale T.L., and Alving C.R. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. Journal of Immunology 161 October (7) (1998) 3211-3214
41. Godefroy S., Goestch L., Plotnicky-Gilquin H., Nguyen T.N., Schmitt D., Staquet M.J., et al. Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV). Vaccine 21 April (15) (2003) 1665-1671
42. Guebre-Xabier M., Hammond S.A., Epperson D.E., Yu J., Ellingsworth L., and Glenn G.M. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. Journal of Virology 77 May (9) (2003) 5218-5225
43. Guerena-Burgueno F., Hall E.R., Taylor D.N., Cassels F.J., Scott D.A., Wolf M.K., et al. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infection and Immunity 70 April (4) (2002) 1874-1880
44. Scharton-Kersten T., Yu J., Vassell R., O'Hagan D., Alving C.R., and Glenn G.M. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infection and Immunity 68 September (9) (2000) 5306-5313
45. Yu J., Cassels F., Scharton-Kersten T., Hammond S.A., Hartman A., Angov E., et al. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infection and Immunity 70 March (3) (2002) 1056-1068